201 related articles for article (PubMed ID: 33891946)
1. Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3.
Leka O; Wu Y; Li X; Kammerer RA
J Biol Chem; 2021; 296():100684. PubMed ID: 33891946
[TBL] [Abstract][Full Text] [Related]
2. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
Pellett S; Bradshaw M; Tepp WH; Pier CL; Whitemarsh RCM; Chen C; Barbieri JT; Johnson EA
mBio; 2018 Mar; 9(2):. PubMed ID: 29588398
[TBL] [Abstract][Full Text] [Related]
3. Catalytic properties of botulinum neurotoxin subtypes A3 and A4.
Henkel JS; Jacobson M; Tepp W; Pier C; Johnson EA; Barbieri JT
Biochemistry; 2009 Mar; 48(11):2522-8. PubMed ID: 19256469
[TBL] [Abstract][Full Text] [Related]
4. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
Davies JR; Rees J; Liu SM; Acharya KR
J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
[TBL] [Abstract][Full Text] [Related]
5. Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity.
Masuyer G; Zhang S; Barkho S; Shen Y; Henriksson L; Košenina S; Dong M; Stenmark P
Sci Rep; 2018 Mar; 8(1):4518. PubMed ID: 29540745
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.
Wang D; Krilich J; Pellett S; Baudys J; Tepp WH; Barr JR; Johnson EA; Kalb SR
Biochim Biophys Acta; 2013 Dec; 1834(12):2722-8. PubMed ID: 24096023
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids.
Smith TJ; Hill KK; Foley BT; Detter JC; Munk AC; Bruce DC; Doggett NA; Smith LA; Marks JD; Xie G; Brettin TS
PLoS One; 2007 Dec; 2(12):e1271. PubMed ID: 18060065
[TBL] [Abstract][Full Text] [Related]
8. Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding.
Gustafsson R; Zhang S; Masuyer G; Dong M; Stenmark P
Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29649119
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of a novel subtype a3 botulinum neurotoxin.
Tepp WH; Lin G; Johnson EA
Appl Environ Microbiol; 2012 May; 78(9):3108-13. PubMed ID: 22367089
[TBL] [Abstract][Full Text] [Related]
10. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
[TBL] [Abstract][Full Text] [Related]
11. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.
Kull S; Schulz KM; Weisemann J; Kirchner S; Schreiber T; Bollenbach A; Dabrowski PW; Nitsche A; Kalb SR; Dorner MB; Barr JR; Rummel A; Dorner BG
PLoS One; 2015; 10(2):e0116381. PubMed ID: 25658638
[TBL] [Abstract][Full Text] [Related]
12. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
Moritz MS; Tepp WH; Bradshaw M; Johnson EA; Pellett S
mSphere; 2018 Oct; 3(5):. PubMed ID: 30355669
[TBL] [Abstract][Full Text] [Related]
13. High-resolution crystal structures of the botulinum neurotoxin binding domains from subtypes A5 and A6.
Davies JR; Britton A; Liu SM; Acharya KR
FEBS Open Bio; 2020 Aug; 10(8):1474-1481. PubMed ID: 32654405
[TBL] [Abstract][Full Text] [Related]
14. A DARPin promotes faster onset of botulinum neurotoxin A1 action.
Leka O; Wu Y; Zanetti G; Furler S; Reinberg T; Marinho J; Schaefer JV; Plückthun A; Li X; Pirazzini M; Kammerer RA
Nat Commun; 2023 Dec; 14(1):8317. PubMed ID: 38110403
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside.
Gregory KS; Liu SM; Acharya KR
FEBS Open Bio; 2020 Mar; 10(3):298-305. PubMed ID: 31945264
[TBL] [Abstract][Full Text] [Related]
16. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4.
Arndt JW; Jacobson MJ; Abola EE; Forsyth CM; Tepp WH; Marks JD; Johnson EA; Stevens RC
J Mol Biol; 2006 Sep; 362(4):733-42. PubMed ID: 16938310
[TBL] [Abstract][Full Text] [Related]
17. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
Ambrin G; Kumar R; Singh BR
Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the functional activity of botulinum neurotoxin subtype B6.
Kohda T; Nakamura K; Hosomi K; Torii Y; Kozaki S; Mukamoto M
Microbiol Immunol; 2017 Nov; 61(11):482-489. PubMed ID: 28898517
[TBL] [Abstract][Full Text] [Related]
19. Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity.
Ahmed SA; Olson MA; Ludivico ML; Gilsdorf J; Smith LA
Protein J; 2008 Apr; 27(3):151-62. PubMed ID: 18213512
[TBL] [Abstract][Full Text] [Related]
20. Resolution of Two Steps in Botulinum Neurotoxin Serotype A1 Light Chain Localization to the Intracellular Plasma Membrane.
Gardner A; Tepp WH; Bradshaw M; Barbieri JT; Pellett S
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]